Doctor Jurgen Bogoviku
University hospital Jena, Jena (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Acute heart failure - pharmacotherapy
Kidney parameters of the EMPAGHF cohort.
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Latest science in heart failure 2
Acute effect of empagliflozin on serum uric acid - a subanalysis of the EMPAG-HF trial (effects of empagliflozin on diuresis and renal function in patients with acute decompensated heart failure)
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Chronic heart failure - Pharmacotherapy
Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)
Event: Heart Failure 2022
Topic: Pharmacotherapy
Session: Heart Failure ePosters - focus on Chronic Heart Failure 6
ESC 365 is supported by
